Publications database

This single programming document (SPD) covers the period 2022–2024. It is presented in line with the guidelines of the European Commission for a single programming document and the consolidated annual activity report...

During the year 2021 new roadmaps were defined for the agency’s Strategy 2025 and for its accompanying document, the Reitox Development Framework (RDF). These two roadmaps describe the activities and milestones to...

In 2017, when the Reitox Development Framework (RDF) was prepared and adopted, one of the key issues underlined by the Centre and the network alike was the need to ensure its execution...

The new Single programming document sets out the EMCDDA’s activities for the period 2021–2023, marking the start of a new five-year roadmap under Strategy 2025. At the heart of the agency’s work...

The Programming Document 2020-22 translates the long-term priorities defined by the EMCDDA Strategy 2025 into short-term operational priorities. The year 2020 marks the end of the first strategic roadmap and the beginning...

This is the first Programming Document fully grounded in the EMCDDA Strategy 2025 and it sets a milestone in the strategic and operational planning framework of the EMCDDA. Among the highlights for...

This document is an update of the International Cooperation Strategy adopted in 2007. It sets priorities in the area of the international cooperation aligned with the Centre’s Strategy 2025.

For more than 20 years, the European information network on drugs and drug addiction (Reitox), has been the cornerstone of the European drug monitoring and reporting system, to which it contributes by...

The EMCDDA Programming Document for the period 2018–20 covers the final year of implementation of the EMCDDA Strategy 2016–18 and coincides with the completion of the first Roadmap established under the new...

This strategy sets out an ambitious course of travel for the agency to 2025. It presents a vision to contribute to a healthier and more secure Europe, through better informed drug policy...